Aung M. Tun

760 total citations
45 papers, 479 citations indexed

About

Aung M. Tun is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aung M. Tun has authored 45 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 20 papers in Pathology and Forensic Medicine and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aung M. Tun's work include Lymphoma Diagnosis and Treatment (19 papers), CAR-T cell therapy research (16 papers) and Viral-associated cancers and disorders (7 papers). Aung M. Tun is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), CAR-T cell therapy research (16 papers) and Viral-associated cancers and disorders (7 papers). Aung M. Tun collaborates with scholars based in United States, United Kingdom and Canada. Aung M. Tun's co-authors include Kyaw Zin Thein, Thein Hlaing Oo, Zin Myint, Hayder Saeed, Ijaz A. Khan, Stephen M. Ansell, Ashish Gupta, Terrence J. Sacchi, Balendu C. Vasavada and Irfan Khan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aung M. Tun

40 papers receiving 470 citations

Peers

Countries citing papers authored by Aung M. Tun

Since Specialization

Citations

This map shows the geographic impact of Aung M. Tun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aung M. Tun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aung M. Tun more than expected).

Fields of papers citing papers by Aung M. Tun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aung M. Tun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aung M. Tun. The network helps show where Aung M. Tun may publish in the future.

Co-authorship network of co-authors of Aung M. Tun

This figure shows the co-authorship network connecting the top 25 collaborators of Aung M. Tun. A scholar is included among the top collaborators of Aung M. Tun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aung M. Tun. Aung M. Tun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fixed treatment duration subcutaneous mosunetuzumab monotherapy in elderly/unfit patients with previously untreated diffuse large B-cell lymphoma: Interim results from the Phase II MorningSun study 2025 ·Blood ·Jeff P. Sharman, Aung M. Tun, José C. Villasboas, Ayed O. Ayed, (unknown), (unknown), Mei Wu, (unknown), Yong Mun, Vivek S. Chopra, (unknown), Jamal Misleh, Shachar Peles, Ian W. Flinn, John M. Burke	0
2	Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy 2024 ·Haematologica ·Aung M. Tun, Yucai Wang, Seth Maliske, Ivana N. Micallef, David J. Inwards, Thomas M. Habermann, Luis F. Porrata, Jonas Paludo, José C. Villasboas, Allison Rosenthal, Mohamed A. Kharfan‐Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston	4
3	Fixed-Duration Subcutaneous Mosunetuzumab Is Active and Has a Manageable Safety Profile in Patients with Previously Untreated, Low-Tumor Burden Follicular Lymphoma: Updated Results from the Phase II Morningsun Study 2024 ·Blood ·John M. Burke, Ian W. Flinn, Lihua E. Budde, Aung M. Tun, Steven Liu, (unknown), (unknown), Mei Wu, Yong Mun, Vivek S. Chopra, Jessica M. Grindheim, (unknown), José C. Villasboas	2
4	Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy 2024 ·Transplantation and Cellular Therapy ·Aung M. Tun, Yucai Wang, Seth Maliske, Ivana N. Micallef, David J. Inwards, Thomas M. Habermann, Luis F. Porrata, Jonas Paludo, José C. Villasboas, Allison Rosenthal, Mohamed A. Kharfan‐Dabaja, Stephen M. Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B. Johnston	1
5	Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma. 2024 ·Journal of Clinical Oncology ·Yucai Wang, Melissa C. Larson, Anita Kumar, Brian T. Hill, David A. Bond, Brad S. Kahl, Alexey V. Danilov, Reid W. Merryman, Natalie S. Grover, Aung M. Tun, Sabarish Ayyappan, Georgios Pongas, Craig A. Portell, Javier Muñoz, Patrick M. Reagan, Muhamad Alhaj Moustafa, Priyanka A. Pophali, Irl Brian Greenwell, Jonathon B. Cohen, Peter Martin	1
6	Anti‐CD19 chimeric antigen receptor T‐cell therapy in older patients with relapsed or refractory large B‐cell lymphoma: A multicenter study 2024 ·American Journal of Hematology ·Aung M. Tun, Romil Patel, (unknown), (unknown), Alex Niu, (unknown), (unknown), Allison Rosenthal, Priyanka A. Pophali, Timothy S. Fenske, Reem Karmali, Sairah Ahmed, Patrick B. Johnston	4
7	Etctn P10500: Phase 1 Study of Tazemetostat Plus Belinostat for the Treatment of Relapsed or Refractory Lymphoma 2024 ·Blood ·Jennifer E. Amengual, Aung M. Tun, (unknown), (unknown), Victor Yazbeck, (unknown), Seda S. Tolu, Barbara Pro, Diane E. Durecki, Jan H. Beumer, Neil L. Kelleher, (unknown), (unknown), (unknown), (unknown), Yu Shyr, Patricia LoRusso, Lorraine Pelosof, Richard Piekarz	2
8	Impact of Absolute Lymphocyte Count on Efficacy and Toxicity of T-Cell Engagers in Non-Hodgkin's Lymphoma 2024 ·Blood ·(unknown), Nausheen Ahmed, Aqeeb Ur Rehman, Muhammad Umair Mushtaq, Aung M. Tun, Al‐Ola Abdallah, Marc Hoffmann, Forat Lutfi	0
9	Mantle Cell Lymphoma Presenting as Cholecystitis and Nephromegaly 2023 ·Cureus ·(unknown), (unknown), (unknown), Aung M. Tun, (unknown)	1
10	Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant 2023 ·HemaSphere ·Aung M. Tun, Yucai Wang, Aasiya Matin, David J. Inwards, Thomas M. Habermann, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Jonas Paludo, José C. Villasboas, Allison Rosenthal, Han W. Tun, James R. Cerhan, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M. Ansell	1
11	Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study 2022 ·Blood Advances ·Aung M. Tun, Arushi Khurana, Raphael Mwangi, Brian K. Link, Yucai Wang, Andrew L. Feldman, Carrie A. Thompson, Anne J. Novak, José C. Villasboas, Gita Thanarajasingam, Umar Farooq, Sergei Syrbu, Grzegorz S. Nowakowski, Thomas E. Witzig, Stephen M. Ansell, Lisa M. Rimsza, James R. Cerhan, Thomas M. Habermann, Matthew J. Maurer	7
12	Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma 2021 ·Blood Cancer Journal ·Alessia Castellino, Aung M. Tun, Yucai Wang, Thomas M. Habermann, Rebecca L. King, Kay M. Ristow, James R. Cerhan, David J. Inwards, Jonas Paludo, Stephen M. Ansell, Thomas E. Witzig, Grzegorz S. Nowakowski	7
13	Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience 2021 ·Clinical Lymphoma Myeloma & Leukemia ·N. Nora Bennani, Aung M. Tun, Kenneth R. Carson, J.L. Geiger, Lauren S. Maeda, Kerry J. Savage, (unknown), Lauren Pinter‐Brown, Matthew A. Lunning, Jeremy S. Abramson, Nancy L. Bartlett, Julie M. Vose, Andrew M. Evens, Sonali M. Smith, Steven M. Horwitz, Stephen M. Ansell, Ranjana H. Advani	1
14	Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience 2021 ·Clinical Lymphoma Myeloma & Leukemia ·N. Nora Bennani, Aung M. Tun, Kenneth R. Carson, J.L. Geiger, Lauren S. Maeda, Kerry J. Savage, (unknown), Lauren Pinter‐Brown, Matthew A. Lunning, Jeremy S. Abramson, Nancy L. Bartlett, Julie M. Vose, Andrew M. Evens, Sonali M. Smith, Steven M. Horwitz, Stephen M. Ansell, Ranjana H. Advani	1
15	Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies 2020 ·Cancer Treatment Reviews ·Aung M. Tun, Stephen M. Ansell	22
16	Molecular Genetics and the Role of Molecularly Targeted Agents in Metastatic Colorectal Carcinoma 2019 ·Journal of Gastrointestinal Cancer ·Naeem Ahmed, Aung M. Tun, (unknown)	6
17	Pneumonia with normal computed tomography of the chest: An atypical presentation of Pneumocystis 2019 ·IDCases ·(unknown), Aung M. Tun, Robert Beck	0
18	Updated Meta-Analysis of Randomized Controlled Trials to Evaluate the Incidence of Infection and Pneumonia in Patients with Multiple Myeloma Treated with Daratumumab 2019 ·Blood ·(unknown), Aung M. Tun, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Fred Hardwicke, Donald P. Quick, Nicholas D’Cunha, (unknown), Kyaw Zin Thein	5
19	Vitamin B12 Deficiency-Related Pseudo-Thrombotic Microangiopathy Might be Misdiagnosed and Treated with Plasma Product Therapy: Review of the Literature and Analysis of the Reported Cases 2017 ·Blood ·Aung M. Tun, Zin Myint, Cristhiam Rojas Hernandez, (unknown), Kyaw Zin Thein, Thein Hlaing Oo	12
20	Myocardial Infarction with Normal Coronary Arteries: The Pathologic and Clinical Perspectives 2001 ·Angiology ·Aung M. Tun, Ijaz A. Khan	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact